Stem-Like Cells and Therapy Resistance in Squamous Cell Carcinomas

Advances in Pharmacology

Volumn 65, Issue , 2012, Pages 235-265

  Facompre, Nicole ^a,b   Nakagawa, Hiroshi ^a   Herlyn, Meenhard ^b   Basu, Devraj ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cancer stem cells; Drug resistance; Squamous cell carcinoma

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; BMI1 PROTEIN; BORTEZOMIB; BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CD133 ANTIGEN; CD44V ANTIGEN; CISPLATIN; DOCETAXEL; GLUCOSE REGULATED PROTEIN 78; MITOXANTRONE; NEUROTROPHIN RECEPTOR P75; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; SCATTER FACTOR RECEPTOR; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CELL ACTIVITY; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

EID: 84865836244     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397927-8.00008-7     Document Type: Chapter

References (113)

1. Abdul-Ghani R., Serra V., Gyorffy B., Jurchitt K., Solf A., Dietel M., et al. The PI3K inhibitor LY294002 blocs drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 2006, 25:1743-1752.
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academies of Science 2003, 100:3983-3988.
3. Ang K.K., Harris J., Wheeler R., Weber R., Rosenthal D.I., Nguyen-Tân P.F., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine 2010, 363:24-35.
4. Argiris A., Karamouzis M.V., Raben D., Ferris R.L. Head and neck cancer. The Lancet 2008, 371:1695-1709.
5. Basu D., Nguyen T.-T.K., Montone K.T., Zhang G., Wang L.-P., Diehl J.A., et al. Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity. Oncogene 2010, 22:4170-4182.
6. Basu D., Montone K.T., Wang L.P., Gimotty P.A., Hammond R., Diehl J.A., et al. Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle 2011, 10:2008-2016.
7. Biddle A., Liang X., Gammon L., Fazil B., Harper L.J., Emich H., et al. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Research 2011, 71:5317-5326.
8. Blanpain C., Lowry W.E., Pasolli H.A., Fuchs E. Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes & Development 2006, 20:3022-3035.
9. Boiko A.D., Razorenova O.V., van de Rijn M., Swetter S.M., Johnson D.L., Ly D.P., et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010, 466:133-137.
10. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997, 94:5320-5325.
11. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
12. Brabletz S., Schmalhofer O., Brabletz T. Gastrointestinal stem cells in development and cancer. Journal of Pathology 2009, 217:307-317.
13. Bragado P., Estrada Y., Sosa M.S., Avivar-Valderas A., Cannan D., Genden E., et al. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties. PLoS One 2012, 7:e29974.
14. Campagnolo L., Russo M.A., Puglianiello A., Favale A., Siracusa G. Mesenchymal cell precursors of peritubular smooth muscle cells of the mouse testis can be identified by the presence of the p75 neurotrophin receptor. Biology of Reproduction 2001, 64l:464-472.
15. Chen Y.-C., Chen Y.-W., Hsu H.-S., Tseng L.-M., Huang P.-I., Lu K.-H., et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochemical and Biophysical Research Communications 2009, 385:307-313.
16. Chen Y.-C., Chang C.-J., Hsu H.-S., Chen Y.-W., Tai L.-K., Tseng L.-M., et al. Inhibition of tumorigenicity and enhancement of radiosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncology 2010, 46:158-165.
17. Chen Y.-S., Wu M.-J., Huang C.-Y., Lin S.-C., Chuang T.-H., Yu C.-C., et al. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One 2011, 6:e28053.
18. Chen C., Wei Y., Hummel M., Hoffmann T.K., Gross M., Kaufmann A.M., et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011, 6:e16466.
19. + head and neck squamous cell carcinoma cells. Head & Neck 2012, 34:336-343.
20. Chiou S.-H., Yu C.-C., Huang C.-Y., Lin S.-C., Liu C.-J., Tsai T.-H., et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clinical Cancer Research 2008, 14:4085-4095.
21. Chiu C.C., Lin C.Y., Lee L.Y., Chen Y.J., Kuo T.F., Chang J.T., et al. Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. Molecular Cancer Therapeutics 2008, 7:2788-2797.
22. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., et al. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Research 2006, 66:9339-9344.
23. Clay M.R., Tabor M., Owen J., Carey T.E., Bradford C.R., Wolf G.T., et al. Single marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head & Neck 2010, 32:1195-1201.
24. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 2005, 65:10956-10957.
25. Conboy I.M., Rando T.A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Developmental Cell 2001, 3:397-409.
26. Cordo Russo R.I., García M.G., Alaniz L., Blanco G., Alvarez E., Hajos S.E. Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. International Journal of Cancer 2008, 122:1012-1018.
27. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., et al. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academies of Science 2007, 104:10158-10163.
28. Deleyrolle L.P., Harding A., Cato K., Siebzehnrubl F.A., Rahman M., Azari H., et al. Evidence for label-retaining tumor-initiating cells in human glioblastoma. Brain 2011, 134:1331-1343.
29. De Herdt M.J., Baatenburg de Jong R.J. HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma. Frontiers in Bioscience 2008, 13:2516-2526.
30. Dembinski J.L., Krauss S. Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clinical & Experimental Metastasis 2009, 26:611-623.
31. Di Renzo M.F., Olivero M., Martone T., Maffe A., Maggiora P., Stefani A.D., et al. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 2000, 19:1547-1555.
32. Douville J., Beaulieu R., Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells & Development 2009, 18:17-25.
33. Fillmore C.M., Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Research 2008, 10. Epub 2008 Mar 26.
34. Fre S., Huyghe M., Mourikis P., Robine S., Louvard D., Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005, 435:964-968.
35. García M.G., Alaniz L.D., Cordo Russo R.I., Alvarez E., Hajos S.E. PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leukemia Research 2009, 33:288-296.
36. Gentile A., Trusolino L., Comoglio P.M. The Met tyrosine kinase receptor in development and cancer. Cancer & Metastasis Reviews 2008, 27:85-94.
37. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine 1996, 183:1797-1806.
38. Gonzalez-Gronow M., Angelica M.A., Papalas J., Pizzo S.V. GRP78: a multifunctional receptor on the cell surface. Antioxidants & Redox Signaling 2009, 11:2299-2306.
39. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Reviews Cancer 2002, 2:45-58.
40. Grant S., Dent P. Kinase inhibitors and cytotoxic drug resistance. Clinical Cancer Research 2004, 10:2205-2207.
41. Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 2011(146):633-644.
42. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
43. NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer 2009, 9:9-20.
44. Janes S.M., Watt F.M. New roles for integrins in squamous-cell carcinoma. Nature Reviews Cancer 2006, 6:175-183.
45. Joshua B., Kaplan M.J., Doweck I., Pai R., Weissman I.L., Prince M.E., et al. Frequency of cells expressing CD44, a head and neck stem cell marker: correlation with tumor aggressiveness. Head & Neck 2012, 34:42-49.
46. Judd N.P., Winkler A.E., Murillo-Sauca O., Brotman J.J., Law J.H., Lewis J.S., et al. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Research 2012, 72:365-374.
47. Kastan M.B., Schlaffer E., Russo J.E., Colvin O.M., Civin C.I., Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990, 75:1947-1950.
48. Keysar S.B., Jimeno A. More than markers: biological significance of cancer stem cell-defining molecules. Molecular Cancer Therapeutics 2010, 9:2450-2457.
49. Korkaya H., Paulson A., Charafe-Jauffret E., Ginestier C., Brown M., Dutcher J., et al. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biology 2009, 7:e1000121.
50. Krishnamurthy S., Dong Z., Vodopyanov D., Imai A., Helma J.I., Prince M.E., et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Research 2010, 70:9969-9978.
51. Kruyt F.A., Schuringa J.J. Apoptosis and cancer stem cells: implications fro apoptosis targeted therapy. Biochemical Pharmacology 2010, 80:423-430.
52. Kusumbe A.P., Bapat S.A. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Research 2009, 69:9245-9253.
53. Lane S.W., Gilliland D.G. Leukemia stem cells. Seminars in Cancer Biology 2010, 20:71-76.
54. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Carceres-Cortes J., et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994, 367:645-648.
55. Le Roy H., Zuliani T., Wolowczuk I., Faivre N., Juoy N., Masselot B., et al. Asymmetric distribution of epidermal growth factor receptor directs the fate of normal and cancer keratinocytes in vitro. Stem Cells & Development 2010, 19:209-220.
56. Lee J.T., Steelman L.S., McCubrey J.A. Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells. Cancer Research 2004, 64:8397-8404.
57. Li H., Gao Q., Guo L., Lu H.S. The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biology & Therapy 2011, 11:950-958.
58. Lim Y.C., Oh S.-Y., Cha Y.Y., Kim S.-H., Jin X., Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncology 2011, 47:83-91.
59. Lo J.-F., Yu C.-C., Chiou S.-H., Huang C.-Y., Jan C.-I., Lin S.-C., et al. The epithelial-mesenchymal transition mediator maintains cancer-initiating cells in head and neck cancers. Cancer Research 2011, 71:1912-1923.
60. Loebinger M.R., Giangreco A., Groot K.R., Prichard L., Allen K., Simpson C., et al. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. British Journal of Cancer 2008, 98:380-387.
61. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics 2006, 38:431-440.
62. Luo S., Mao C., Lee B., Lee A.S. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Molecular & Cellular Biology 2006, 26:5688-5697.
63. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
64. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90:5013-5021.
65. Moitra K., Lou H., Dean M. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clinical Pharmacology & Therapeutics 2011, 89:491-502.
66. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-967.
67. Moore N., Lyle S. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. Journal of Oncology 2011, Epub 2010 Sep 29.
68. Moore N., Houghton J., Lyle S. Slow-cycling therapy-resistant cancer cells. Stem Cells & Development 2011, Epub 2011 Nov 11.
69. Morel A.P., Lièvre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3:e2888.
70. Naor D., Nedvetzki S., Golan I., Melnik L., Faitelson Y. CD44 in cancer. Critical Reviews in Clinical Laboratory Sciences 2002, 39:527-579.
71. Naor D., Wallach-Dayan S.B., Zahalka M.A., Sionov R.V. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Seminars in Cancer Biology 2008, 18:260-267.
72. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007, 445:106-110.
73. Ohashi S., Natsuizaka M., Yashiro-Ohtani Y., Kalman R.A., Nakagawa M., Wu L., et al. NOTCH1 and NOT CH3 coordinate esophageal squamous differentiation through a CSL-dependent network. Gastroenterology 2010, 139:2113-2123.
74. Ohashi S., Natsuizaka M., Naganuma S., Kagawa S., Kimura S., Itoh H., et al. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Research 2011, 71:6836-6847.
75. Okamoto A., Chikamatsu K., Sakakura K., Hatsushika K., Takahashi G., Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncology 2009, 45:633-639.
76. Okumura T., Shimada Y., Imamura M., Yasumoto S. Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 2003, 22:4017-4026.
77. Ola M.S., Nawaz M., Ahsan H. Role of Bcl-2 family proteins and caspase in the regulation of apoptosis. Molecular & Cellular Biochemistry 2011, 35:41-58.
78. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423:302-305.
79. Park I.K., Morrison S.J., Clarke M.F. Bmi1, stem cells, and senescence regulation. Journal of Clinical Investigation 2004, 113:175-179.
80. Park D., Xiang A.P., Mao F.F., Zhang L., Di C.G., Liu X.M., et al. Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 2010, 28:2162-2171.
81. Pastrana E., Silva-Vargas V., Doetsch F. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 2011, 8:486-498.
82. Pellegrini G., Dellambra E., Golisano O., Martinelli E., Fantozzi I., Bondanza S., et al. P63 identifies keratinocyte stem cells. Proceedings of the National Academies of Science 2001, 98:3156-3161.
83. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academies of Science 2007, 104:973-978.
84. Qi H., Li D.Q., Shine H.D., Chen Z., Yoon K.C., Jones D.B., et al. Nerve growth factor and its receptor TrkA serve as potential markers for human corneal epithelial progenitors. Experimental Eye Research 2008, 86:34-40.
85. Quintana E., Shackleton M., Sable M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumor formation by single human melanoma cells. Nature 2008, 456:593-599.
86. Quintana E., Shackleton M., Foster H.R., Fullen D.R., Sabel M.S., Johnson T.M., et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and hierarchically organized. Cancer Cell 2010, 18:510-523.
87. Reynolds B.A., Weiss S. Generation of neurons and astrocytes form isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
88. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
89. Roesch A., Fukunaga-Kalabis M., Schmidt E.C., Zabierowski S.E., Brafford P.A., Vultur A., et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141:583-594.
90. Sarkadi B., Ozvegy-Laczka C., Nemet K., Varadi A. ABCG2 - a transported for all seasons. FEBS Letters 2004, 567:116-120.
91. Scharenberg C.W., Karkey M.A., Torok-Storb B. The ABCG transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99:507-512.
92. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., et al. Nature 2008, 451:345-349.
93. Sharma S.V., Lee D.Y., Li B., Quinlan M.P., Takahashi F., Maheswaran S., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
94. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumor initiating cells. Nature 2004, 432:396-401.
95. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
96. Sterz C.M., Kulle C., Dakic B., Makarova G., Bottcher M., Bette M., et al. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncology 2010, 46:116-122.
97. Storms R.W., Trujillo A.P., Springer J.B., Shah L., Colvin O.M., Ludeman S.M. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proceedings of the National Academies of Science 1999, 96:9118-9123.
98. Sun G., Fujii M., Sonoda A., Tokumaru Y., Matsunaga T., Habu N. Identification of stem-like cells in head and neck cancer cell lines. Anticancer Research 2010, 30:2005-2010.
99. + cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. International Journal of Cancer 2011, 129:2337-2348.
100. Tabor M.H., Clay M.R., Owen J.H., Bradford C.R., Carey T.E., Wolf G.T., et al. Head and neck cancer stem cells: the side population. The Laryngoscope 2011, 121:527-533.
101. Tang A.L., Hauff S.J., Owen J.H., Graham M.P., Czerwinski M.J., Park J.J., et al. UM-SCC-104: a new human papillomavirus-16-positice cancer stem cell-containing head and neck squamous cell carcinoma line. Head and Neck 2011, Epub 2011 Dec 13.
102. Tsai L.-L., Yu C.-C., Chang Y.-C., Yu C.-H., Chou M.-Y. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Oral Pathology & Medicine 2011, 40:621-628.
103. Tsunoda S., Okumura T., Ito T., Kondo K., Ortiz C., Tanaka E., et al. ABCG2 expression is an independent prognostic factor in esophageal squamous cell carcinoma. Oncology 2006, 71:251-258.
104. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nature Reviews Cancer 2008, 8:755-768.
105. Wu M.-J., Jan C.-I., Tsay Y.-G., Yu Y.-H., Huang C.-Y., Lin S.-C., et al. Elimination of head and neck cancer initiating cells through targeted glucose regulated protein78 signaling. Molecular Cancer 2010, 9:283-298.
106. Yajima T., Ochiai H., Uchiyama T., Takano N., Shibahara H., Azuma T. Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1. International Journal of Oncology 2009, 35:273-280.
107. Yamamoto N., Akamatsu H., Hasegawa S., Yamada T., Nakata S., Ohkuma M., et al. Isolation of multipotent stem cells from mouse adipose tissue. Journal of Dermatological Science 2007, 48:43-52.
108. Yanamoto S., Kawasaki G., Yamada S., Yoshitomi I., Kawano T., Yonezawa H., et al. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncology 2011, 47:855-860.
109. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Developmental Cell 2008, 14:818-829.
110. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012.
111. Zhang Q., Shi S., Yen Y., Brown J., Ta J.Q., Le A.D. A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confers resistance to chemotherapy. Cancer Letters 2010, 289:151-160.
112. Zhao J.-S., Li W.-J., Ge D., Zhang P.-J., Li J.-J., Lu C.-L., et al. Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS One 2011, 6:e21419.
113. Zoller M. CD44: can c cancer-initiating cells profit from an abundantly expressed molecule. Nature Reviews Cancer 2011, 11:254-267.